Income Statement Fuchs SE

Stocks

FPE3

DE000A3E5D64

Commodity Chemicals

Market Closed - Xetra Other stock markets 16:37:00 21/07/2026 BST			5-day change	1st Jan Change
39.54 ^EUR	+0.61%		-0.45%	+3.67%

07-15	BASF shares slide despite higher profit target, cash flow in focus	DP
07-15	BASF drags the chemicals sector lower	DP

ffac.Q1ckuYHD6SmKMzfbTywEOfBxA0bt0ekmCV3HUkNisfY.dgFx_8Cp2kX6HmCTK2RcYLNIegGftIpTXC31B3UI24UoP0n9yKjdYrpcRA

Published financial data: FUCHS SE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	2.87B	3.41B	3.54B	3.52B	3.56B
Total Revenues	2.87B	3.41B	3.54B	3.52B	3.56B
Cost of Goods Sold, Total	1.91B	2.37B	2.4B	2.32B	2.33B
Gross Profit	957M	1.05B	1.14B	1.21B	1.24B
Selling General & Admin Expenses, Total	554M	614M	650M	697M	716M
R&D Expenses	57M	67M	69M	77M	81M
Other Operating Expenses	-9M	1M	3M	-2M	7M
Other Operating Expenses, Total	602M	682M	722M	772M	804M
Operating Income	355M	364M	414M	436M	433M
Interest Expense, Total	-5M	-9M	-12M	-9M	-11M
Interest And Investment Income	-	1M	2M	3M	4M
Net Interest Expenses	-5M	-8M	-10M	-6M	-7M
Income (Loss) On Equity Invest.	9M	9M	7M	8M	10M
Currency Exchange Gains (Loss)	1M	-6M	-4M	-2M	0
EBT, Excl. Unusual Items	360M	359M	407M	436M	436M
Restructuring Charges	-2M	-2M	-4M	-8M	-6M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Assets	0	1M	4M	0	-2M
Asset Writedown	-	-1M	-4M	-	-
EBT, Incl. Unusual Items	358M	357M	403M	428M	428M
Income Tax Expense	104M	97M	120M	126M	122M
Earnings From Continuing Operations	254M	260M	283M	302M	306M
Net Income to Company	254M	260M	283M	302M	306M
Minority Interest	-1M	-1M	-1M	-	-
Net Income - (IS)	253M	259M	282M	302M	306M
Net Income to Common Incl Extra Items	253M	259M	282M	302M	306M
Net Income to Common Excl. Extra Items	253M	259M	282M	302M	306M
Per Share Items
Net EPS - Basic	1.82	1.87	2.09	2.3	2.34
Basic EPS - Continuing Operations	1.82	1.87	2.09	2.3	2.34
Basic Weighted Average Shares Outstanding	139M	138M	135M	132M	131M
Net EPS - Diluted	1.82	1.87	2.09	2.3	2.34
Diluted EPS - Continuing Operations	1.82	1.87	2.09	2.3	2.34
Diluted Weighted Average Shares Outstanding	139M	138M	135M	132M	131M
Normalized Basic EPS	1.61	1.61	1.88	2.07	2.08
Normalized Diluted EPS	1.61	1.61	1.88	2.07	2.08
Dividend Per Share	1.03	1.07	1.11	1.17	1.23
Payout Ratio	54.15	54.83	51.06	48.34	50
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	432M	447M	497M	521M	517M
EBITA	377M	387M	437M	459M	454M
EBIT	355M	364M	414M	436M	433M
EBITDAR	437M	452M	503M	527M	522M
Effective Tax Rate - (Ratio)	29.05	27.17	29.78	29.44	28.5
Current Domestic Taxes	42M	39M	56M	49M	52M
Current Foreign Taxes	63M	63M	68M	79M	80M
Total Current Taxes	105M	102M	124M	128M	132M
Deferred Domestic Taxes	2M	-1M	-	1M	-2M
Deferred Foreign Taxes	-3M	-4M	-4M	-3M	-8M
Total Deferred Taxes	-1M	-5M	-4M	-2M	-10M
Normalized Net Income	224M	223M	253M	272M	272M
Interest on Long-Term Debt	1M	1M	1M	2M	3M
Non-Cash Pension Expense	0	0	0	0	0
Supplemental Operating Expense Items
Marketing Expenses	14M	14M	17M	20M	20M
Selling and Marketing Expenses	405M	450M	473M	502M	515M
General and Administrative Expenses	146M	160M	173M	191M	196M
Research And Development Expense From Footnotes	59M	69M	71M	79M	84M
Net Rental Expense, Total	5M	5M	6M	6M	5M
Imputed Operating Lease Interest Expense	5.06M	3.16M	4.76M	4.94M	4.29M
Imputed Operating Lease Depreciation	-63.28K	1.84M	1.24M	1.06M	707K
Maintenance & Repair Expenses, Total	25M	28M	32M	31M	34M
Stock-Based Comp., Other (Total)	1.2M	1.11M	1.4M	1.77M	1.87M
Total Stock-Based Compensation	1.2M	1.11M	1.4M	1.77M	1.87M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	146M	119M	175M	153M	244M
Total Cash And Short Term Investments	146M	119M	175M	153M	244M
Accounts Receivable, Total	433M	509M	502M	520M	516M
Other Receivables	13M	21M	19M	31M	43M
Total Receivables	446M	530M	521M	551M	559M
Inventory	507M	635M	524M	567M	566M
Other Current Assets, Total	22M	34M	23M	14M	12M
Total Current Assets	1.12B	1.32B	1.24B	1.28B	1.38B
Gross Property Plant And Equipment	1.27B	1.33B	1.37B	1.5B	1.51B
Accumulated Depreciation	-524M	-582M	-616M	-692M	-723M
Net Property Plant And Equipment	744M	751M	751M	813M	787M
Long-term Investments	50M	61M	61M	68M	65M
Goodwill	247M	254M	249M	309M	312M
Other Intangibles, Total	104M	89M	71M	78M	101M
Accounts Receivable Long-Term	1M	1M	1M	1M	-
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	35M	38M	38M	39M	44M
Other Long-Term Assets, Total	9M	11M	9M	17M	13M
Total Assets	2.31B	2.52B	2.42B	2.61B	2.7B
Liabilities
Accounts Payable, Total	227M	231M	260M	281M	312M
Accrued Expenses, Total	108M	120M	133M	137M	138M
Current Portion of Long-Term Debt	27M	154M	26M	48M	26M
Current Portion of Leases	8M	7M	9M	12M	12M
Current Income Taxes Payable	24M	18M	32M	41M	35M
Unearned Revenue Current, Total	21M	17M	20M	18M	20M
Other Current Liabilities	38M	47M	45M	43M	51M
Total Current Liabilities	453M	594M	525M	580M	594M
Long-Term Debt	-	3M	7M	10M	6M
Long-Term Leases	14M	15M	21M	42M	49M
Pension & Other Post Retirement Benefits	28M	7M	10M	11M	8M
Deferred Tax Liability Non Current	48M	53M	46M	53M	51M
Other Non Current Liabilities	12M	10M	10M	14M	16M
Total Liabilities	555M	682M	619M	710M	724M
Common Stock, Total	139M	139M	139M	131M	131M
Retained Earnings	253M	259M	282M	302M	306M
Comprehensive Income and Other	1.36B	1.44B	1.38B	1.46B	1.54B
Total Common Equity	1.75B	1.84B	1.8B	1.9B	1.98B
Minority Interest	3M	3M	4M	3M	3M
Total Equity	1.76B	1.84B	1.8B	1.9B	1.98B
Total Liabilities And Equity	2.31B	2.52B	2.42B	2.61B	2.7B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	139M	139M	133M	131M	131M
ECS Total Common Shares Outstanding	139M	139M	133M	131M	131M
Book Value / Share	12.61	13.22	13.53	14.48	15.08
Tangible Book Value	1.4B	1.5B	1.48B	1.51B	1.56B
Tangible Book Value Per Share	10.09	10.76	11.12	11.53	11.93
Total Debt	49M	179M	63M	112M	93M
Net Debt	-97M	60M	-112M	-41M	-151M
Debt Equivalent of Unfunded Proj. Benefit Obligation	23M	0	4M	4M	-1M
Debt Equivalent Oper. Leases	40M	40M	48M	48M	40M
Minority Interest, Total (Incl. Fin. Div)	3M	3M	4M	3M	3M
Equity Method Investments, Total	43M	54M	55M	62M	59M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	216M	261M	203M	218M	210M
Inventories - Work In Process, Total	24M	37M	30M	29M	33M
Inventories - Finished Goods, Total	267M	337M	291M	320M	323M
Land - (BS)	480M	508M	526M	587M	587M
Machinery, Total	734M	769M	798M	877M	877M
Full Time Employees	5.98K	6.1K	6.27K	6.78K	6.88K
Accumulated Allowance for Doubtful Accounts (Supple)	11M	14M	14M	13M	13M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	253M	259M	282M	302M	306M
Depreciation & Amortization - CF	64M	70M	70M	74M	78M
Amortization of Goodwill and Intangible Assets - (CF)	22M	23M	23M	23M	21M
Depreciation & Amortization, Total	86M	93M	93M	97M	99M
(Gain) Loss From Sale Of Asset	-	-1M	-3M	-	1M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	1M	5M	-	-
(Income) Loss On Equity Investments - (CF)	-9M	-1M	-1M	-3M	-2M
Stock-Based Compensation (CF)	1M	-	-	-	-
Other Operating Activities, Total	5M	-6M	-10M	-4M	-8M
Change In Accounts Receivable	-45M	-77M	-6M	-4M	-15M
Change In Inventories	-132M	-131M	89M	-22M	-18M
Change In Accounts Payable	25M	2M	34M	13M	48M
Change in Other Net Operating Assets	-15M	-11M	60M	11M	-5M
Cash from Operations	169M	128M	543M	390M	406M
Capital Expenditure	-80M	-69M	-83M	-83M	-92M
Sale of Property, Plant, and Equipment	1M	2M	5M	1M	2M
Cash Acquisitions	-29M	-2M	-4M	-101M	-27M
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-2M	-
Cash from Investing	-108M	-69M	-82M	-185M	-117M
Long-Term Debt Issued, Total	5M	119M	-	5M	-
Total Debt Issued	5M	119M	-	5M	-
Long-Term Debt Repaid, Total	-	-	-133M	-	-37M
Total Debt Repaid	-	-	-133M	-	-37M
Repurchase of Common Stock	-	-62M	-122M	-79M	-
Common Dividends Paid	-137M	-142M	-144M	-146M	-153M
Common & Preferred Stock Dividends Paid	-137M	-142M	-144M	-146M	-153M
Other Financing Activities, Total	-	-1M	-1M	-8M	-
Cash from Financing	-132M	-86M	-400M	-228M	-190M
Foreign Exchange Rate Adjustments	8M	-	-5M	1M	-8M
Net Change in Cash	-63M	-27M	56M	-22M	91M
Supplemental Items
Cash Interest Paid	5M	9M	12M	9M	11M
Cash Income Tax Paid (Refund)	121M	111M	107M	119M	142M
Levered Free Cash Flow	38.95M	37.99M	451M	249M	304M
Unlevered Free Cash Flow	42.07M	43.61M	458M	254M	310M
Change In Net Working Capital	187M	209M	-188M	34M	-31M
Net Debt Issued / Repaid	5M	119M	-133M	5M	-37M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.01	9.41	10.46	10.83	10.19
Return on Total Capital	12.99	11.9	13.31	14.05	13.25
Return On Equity %	15.23	14.46	15.53	16.31	15.78
Return on Common Equity	15.19	14.42	15.5	16.34	15.8
Margin Analysis
Gross Profit Margin %	33.33	30.66	32.08	34.27	34.72
SG&A Margin	19.3	18	18.36	19.77	20.1
EBITDA Margin %	15.05	13.1	14.04	14.78	14.51
EBITA Margin %	13.13	11.34	12.34	13.02	12.74
EBIT Margin %	12.36	10.67	11.69	12.37	12.15
Income From Continuing Operations Margin %	8.85	7.62	7.99	8.57	8.59
Net Income Margin %	8.81	7.59	7.96	8.57	8.59
Net Avail. For Common Margin %	8.81	7.59	7.96	8.57	8.59
Normalized Net Income Margin	7.8	6.55	7.16	7.73	7.65
Levered Free Cash Flow Margin	1.36	1.11	12.73	7.05	8.52
Unlevered Free Cash Flow Margin	1.47	1.28	12.94	7.21	8.71
Asset Turnover
Asset Turnover	1.3	1.41	1.43	1.4	1.34
Fixed Assets Turnover	3.98	4.56	4.72	4.51	4.45
Receivables Turnover (Average Receivables)	7.14	7.24	7	6.9	6.88
Inventory Turnover (Average Inventory)	4.42	4.14	4.15	4.25	4.11
Short Term Liquidity
Current Ratio	2.47	2.22	2.37	2.22	2.32
Quick Ratio	1.31	1.09	1.33	1.21	1.35
Operating Cash Flow to Current Liabilities	0.37	0.22	1.03	0.67	0.68
Days Sales Outstanding (Average Receivables)	51.11	50.39	52.11	53.06	53.06
Days Outstanding Inventory (Average Inventory)	82.57	88.09	87.95	86.17	88.9
Average Days Payable Outstanding	37.7	33.51	39.06	41.95	46.55
Cash Conversion Cycle (Average Days)	95.98	104.96	100.99	97.28	95.41
Long Term Solvency
Total Debt/Equity	2.79	9.72	3.49	5.89	4.7
Total Debt / Total Capital	2.71	8.86	3.37	5.57	4.49
LT Debt/Equity	0.8	0.98	1.55	2.74	2.78
Long-Term Debt / Total Capital	0.78	0.89	1.5	2.58	2.65
Total Liabilities / Total Assets	24.02	27.03	25.55	27.2	26.78
EBIT / Interest Expense	71	40.44	34.5	48.44	39.36
EBITDA / Interest Expense	88.2	50.78	42.25	59.22	48.36
(EBITDA - Capex) / Interest Expense	72.2	43.11	35.33	50	40
Total Debt / EBITDA	0.11	0.39	0.12	0.21	0.17
Net Debt / EBITDA	-0.22	0.13	-0.22	-0.08	-0.28
Total Debt / (EBITDA - Capex)	0.14	0.46	0.15	0.25	0.21
Net Debt / (EBITDA - Capex)	-0.27	0.15	-0.26	-0.09	-0.34
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	20.73	18.84	3.78	-0.45	1.08
Gross Profit, 1 Yr. Growth %	12.85	9.3	8.6	6.15	2.4
EBITDA, 1 Yr. Growth %	13.98	3.47	11.19	4.83	-0.77
EBITA, 1 Yr. Growth %	14.24	2.65	12.92	5.03	-1.09
EBIT, 1 Yr. Growth %	15.26	2.54	13.74	5.31	-0.69
Earnings From Cont. Operations, 1 Yr. Growth %	14.93	2.36	8.85	6.71	1.32
Net Income, 1 Yr. Growth %	15	2.37	8.88	7.09	1.32
Normalized Net Income, 1 Yr. Growth %	15.09	-0.28	13.43	7.55	0
Diluted EPS Before Extra, 1 Yr. Growth %	15	2.82	11.74	9.76	1.77
Accounts Receivable, 1 Yr. Growth %	16.71	17.55	-1.38	3.59	-0.77
Inventory, 1 Yr. Growth %	41.23	25.25	-17.48	8.21	-0.18
Net Property, Plant and Equip., 1 Yr. Growth %	6.29	0.94	0	8.26	-3.2
Total Assets, 1 Yr. Growth %	9.01	9.17	-3.96	7.72	3.56
Tangible Book Value, 1 Yr. Growth %	14.17	6.63	-1	2.03	3.51
Common Equity, 1 Yr. Growth %	11.02	4.85	-2.07	5.39	4.16
Cash From Operations, 1 Yr. Growth %	-53.06	-24.26	324.22	-28.18	4.1
Capital Expenditures, 1 Yr. Growth %	-34.43	-13.75	20.29	0	10.84
Levered Free Cash Flow, 1 Yr. Growth %	-82.28	-2.46	1.09K	-44.83	22.11
Unlevered Free Cash Flow, 1 Yr. Growth %	-81.18	3.66	950.5	-44.5	22.11
Dividend Per Share, 1 Yr. Growth %	4.04	3.88	3.74	5.41	5.13
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.65	19.78	11.06	1.64	0.31
Gross Profit, 2 Yr. CAGR %	4.16	11.06	8.95	7.47	4.26
EBITDA, 2 Yr. CAGR %	5.11	8.6	7.26	7.96	1.99
EBITA, 2 Yr. CAGR %	4.53	8.29	7.66	8.91	1.93
EBIT, 2 Yr. CAGR %	4.35	8.71	7.99	9.44	2.27
Earnings From Cont. Operations, 2 Yr. CAGR %	5.55	8.47	5.55	7.77	3.98
Net Income, 2 Yr. CAGR %	5.34	8.5	5.58	7.98	4.17
Normalized Net Income, 2 Yr. CAGR %	3.59	7.13	6.36	10.45	3.71
Diluted EPS Before Extra, 2 Yr. CAGR %	5.34	8.74	7.19	10.74	5.69
Accounts Receivable, 2 Yr. CAGR %	6.33	17.13	7.67	1.07	1.38
Inventory, 2 Yr. CAGR %	15.36	33	1.66	-5.51	3.93
Net Property, Plant and Equip., 2 Yr. CAGR %	7.23	3.58	0.47	4.05	2.37
Total Assets, 2 Yr. CAGR %	6.88	9.09	2.39	1.71	5.62
Tangible Book Value, 2 Yr. CAGR %	4.17	10.34	2.74	0.5	2.77
Common Equity, 2 Yr. CAGR %	6.01	7.89	1.33	1.59	4.77
Cash From Operations, 2 Yr. CAGR %	-28.33	-40.37	79.25	74.55	-13.53
Capital Expenditures, 2 Yr. CAGR %	-27.92	-24.8	1.86	9.68	5.28
Levered Free Cash Flow, 2 Yr. CAGR %	-46.54	-58.43	240.16	155.84	-17.92
Unlevered Free Cash Flow, 2 Yr. CAGR %	-44.93	-55.83	230	141.46	-17.68
Dividend Per Share, 2 Yr. CAGR %	3.05	3.96	3.81	4.57	5.27
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.8	9.88	14.19	7.08	1.45
Gross Profit, 3 Yr. CAGR %	2.37	5.85	10.24	8.07	5.75
EBITDA, 3 Yr. CAGR %	1.35	4.56	9.46	6.44	4.97
EBITA, 3 Yr. CAGR %	0.18	3.9	9.81	6.78	5.47
EBIT, 3 Yr. CAGR %	-0.19	3.74	10.36	7.09	5.96
Earnings From Cont. Operations, 3 Yr. CAGR %	-4.1	4.48	8.59	5.94	5.58
Net Income, 3 Yr. CAGR %	-4.23	4.34	8.63	6.08	5.72
Normalized Net Income, 3 Yr. CAGR %	-2.1	2.28	9.19	6.75	6.85
Diluted EPS Before Extra, 3 Yr. CAGR %	-4.23	4.49	9.73	8.04	7.67
Accounts Receivable, 3 Yr. CAGR %	4.36	9.94	10.61	6.29	0.46
Inventory, 3 Yr. CAGR %	7.34	18.56	13.43	3.8	-3.76
Net Property, Plant and Equip., 3 Yr. CAGR %	12.61	5.09	2.37	3	1.57
Total Assets, 3 Yr. CAGR %	6.91	7.64	4.55	4.14	2.32
Tangible Book Value, 3 Yr. CAGR %	6.03	4.98	6.42	2.5	1.49
Common Equity, 3 Yr. CAGR %	6.41	5.62	4.46	2.67	2.44
Cash From Operations, 3 Yr. CAGR %	-14.14	-27	14.68	32.15	46.93
Capital Expenditures, 3 Yr. CAGR %	-12.88	-23.48	-12.05	1.23	10.06
Levered Free Cash Flow, 3 Yr. CAGR %	-25.42	-34.67	27.04	85.51	99.94
Unlevered Free Cash Flow, 3 Yr. CAGR %	-23.81	-32.01	27.02	82.15	92.37
Dividend Per Share, 3 Yr. CAGR %	2.73	3.32	3.89	4.34	4.75
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.84	6.65	6.64	6.51	8.42
Gross Profit, 5 Yr. CAGR %	2.57	3.61	4.95	6.49	7.84
EBITDA, 5 Yr. CAGR %	1.6	1.45	3.67	5.91	6.41
EBITA, 5 Yr. CAGR %	0.48	0.37	3.11	5.88	6.59
EBIT, 5 Yr. CAGR %	0.17	0.06	3.01	5.99	7.05
Earnings From Cont. Operations, 5 Yr. CAGR %	-0.47	-0.68	-0.35	5.78	6.72
Net Income, 5 Yr. CAGR %	-0.47	-0.75	-0.42	5.78	6.82
Normalized Net Income, 5 Yr. CAGR %	-0.66	-1.11	1.2	5.47	6.96
Diluted EPS Before Extra, 5 Yr. CAGR %	-0.47	-0.67	0.19	6.95	8.1
Accounts Receivable, 5 Yr. CAGR %	4.17	6.3	5.67	6.31	6.82
Inventory, 5 Yr. CAGR %	9.3	11.65	5.03	8.28	9.53
Net Property, Plant and Equip., 5 Yr. CAGR %	11.75	9.78	7.59	4.67	2.37
Total Assets, 5 Yr. CAGR %	6.64	7.58	5.08	5.23	4.98
Tangible Book Value, 5 Yr. CAGR %	9.59	7.95	4.71	3.17	4.94
Common Equity, 5 Yr. CAGR %	7.8	7.07	4.35	3.99	4.59
Cash From Operations, 5 Yr. CAGR %	-10.84	-11.96	15.25	3.46	2.43
Capital Expenditures, 5 Yr. CAGR %	-2.97	-8.05	-7.26	-11.63	-5.49
Levered Free Cash Flow, 5 Yr. CAGR %	-25.62	-19.1	36.85	12.78	6.67
Unlevered Free Cash Flow, 5 Yr. CAGR %	-24.63	-17.02	36.94	12.88	6.79
Dividend Per Share, 5 Yr. CAGR %	2.96	3.29	3.16	3.82	4.44